Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: An open-label switch study

Jean Pierre Lindenmayer, Pal Czobor, Jan Volavka, Jeffrey A. Lieberman, Leslie Citrome, Brian Sheitman, Miranda Chakos, Joseph P. McEvoy

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: An open-label switch study'. Together they form a unique fingerprint.

Medicine & Life Sciences